Javier
Rodríguez Rodríguez
Consultor Médico
Christchurch Hospital
Christchurch, Nueva ZelandaPublications in collaboration with researchers from Christchurch Hospital (1)
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731